The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Fecal Colonization With Extended-spectrum Beta-lactamase–Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis
Open accessAbstract
BACKGROUND: Gut colonization is a risk factor for infections with extended-spectrum beta-lactamase (ESBL)-producing organisms. We aimed to determine the ESBL class A reservoir among healthy individuals. METHODS: We searched PubMed and EMBASE (through 10 July 2015) looking for studies that contained data for fecal colonization with ESBL class A bacteria among healthy individuals for each World Health Organization-defined region. Distribution of isolates among cefotaximase (CTX-M), sulfhydryl variable, and temoneira enzymes and data on previous antibiotic use, international travel, previous hospitalization, and animal contacts were extracted. RESULTS: Sixty-six of 17 479 studies on 28 909 healthy individuals were included. The pooled prevalence of ESBL class A colonization was 14% (95% confidence interval [CI], 9, 20), with an increasing trend of 5.38% annually (P = .003). The pooled prevalence was higher in Asia and Africa (ranging from 46%, 95% CI, 29, 63 to 15%, 95% CI, 4, 31) and lower but still significant in central (3%, 95% CI, 1, 5), northern (4%, 95% CI, 2, 6), and southern Europe (6%, 95% CI, 1, 12) and the Americas (2%, 95% CI, 0, 5). CTX-Ms were the prevalent ESBL enzyme (69%). Antibiotic use for the prior 4 or 12 months was associated with a high colonization risk (risk ratio [RR] = 1.63; 95% CI, 1.19, 2.24 and RR = 1.58; 95% CI, 1.16, 2.16, respectively). International travel was also correlated with ESBL colonization [(RR = 4.06, (95% CI, 1.33, 12.41)]. CONCLUSIONS: The ESBL colonization rate among healthy individuals is significant worldwide. This should be taken into consideration in infection control and antibiotic management decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
CTX-M-type β-lactamases: A successful story of antibiotic resistance
D’Andrea, M. M., Arena, F., Pallecchi, L., & Rossolini, G. M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.008 · Cited by 429
The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens
Donskey, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422002 · Cited by 424
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F., & Cantón, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4769-4775.2004 · Cited by 333
Gales, A. C., Castanheira, M., Jones, R. N., & Sader, H. S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.007 · Cited by 318
The gut is the epicentre of antibiotic resistance
Carlet, J. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-39 · Cited by 214
Lübbert, C., Straube, L., Stein, C., Makarewicz, O., Schubert, S., Mössner, J., Pletz, M. W., & Rodloff, A. C. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.12.001 · Cited by 204
Reddy, P., Malczynski, M., Obias, A., Reiner, S., Jin, N., Huang, J., Noskin, G. A., & Zembower, T. (2007) · Clinical Infectious Diseases · doi:10.1086/521260 · Cited by 189
Nicolas-Chanoine, M.-H., Gruson, C., Bialek-Davenet, S., Bertrand, X., Thomas-Jean, F., Bert, F., Moyat, M., Meiller, E., Marcon, E., Danchin, N., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks429 · Cited by 168
Leflon‐Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L., & Nicolas-Chanoine, M.-H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00734-08 · Cited by 144
Tschudin‐Sutter, S., Frei, R., Dangel, M., Stranden, A., & Widmer, A. F. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis770 · Cited by 132
Geser, N., Stephan, R., Korczak, B. M., Beutin, L., & Hächler, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05539-11 · Cited by 122
Bert, F., Larroque, B., Paugam‐Burtz, C., Dondero, F., Durand, F., Marcon, E., Belghiti, J., Moreau, R., & Nicolas-Chanoine, M.-H. (2012) · Emerging infectious diseases · doi:10.3201/eid1806.110139 · Cited by 115
Rodríguez‐Baño, J., Navarro, M. D., Romero, L., Muniain, M. A., de Cueto, M., Gálvez-Acebal, J., Perea, E. J., & Pascual, Á. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01884.x · Cited by 110
de Champs, C., Sirot, D., Chanal, C., Poupart, M. C., Dumas, M.-P., & Sirot, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.4.441 · Cited by 108
Sallem, R. B., Slama, K. B., Estepa, V., Jouini, A., Gharsa, H., Klibi, N., Sáenz, Y., Ruiz‐Larrea, F., Boudabous, A., & Torres, C. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1471-z · Cited by 97
Sasaki, T., Hirai, I., Niki, M., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq008 · Cited by 94
Troché, G., Toly, L.-M., Guibert, M., & Zazzo, J. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502521 · Cited by 84
Nakayama, T., Ueda, S., Huong, B. T. M., Tuyên, L. D., Komalamisra, C., Kusolsuk, T., Hirai, I., & Yamamoto, Y. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s74934 · Cited by 69
Woerther, P., Angebault, C., Lescat, M., Ruppé, É., Skurnik, D., Mniai, A. E., Clermont, O., Jacquier, H., Costa, A. D., Renard, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/654883 · Cited by 64
Machado, E., Coque, T. M., Cantón, R., Sousa, J. C., & Peixe, L. M. S. V. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00080 · Cited by 47
Janvier, F., Mérens, A., Delaune, D., Soler, C., & Cavallo, J.-D. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.07.012 · Cited by 34
Cited by
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Bevan, E. R., Jones, A. M., & Hawkey, P. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx146 · Cited by 791
Environmental antimicrobial resistance and its drivers: a potential threat to public health
Samreen, Ahmad, I., Malak, H. A., & Abulreesh, H. H. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.08.001 · Cited by 727
Bloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D. A., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 334
Metadata
- Authors
- Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., & Mylonakis, E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-03
- Volume
- 63
- Issue
- 3
- Pages
- 310-318
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2345699608
- Cited by
- 453
- References
- 31
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.